FDA Warning Letter — Spectrum Laboratory Products, Inc.
The FDA took a Warning Letter action against Spectrum Laboratory Products, Inc. on Jul 31, 2019 (New Brunswick, NJ). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Spectrum Laboratory Products, Inc.
- Date
- Jul 31, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Center
- CDER
- Location
- New Brunswick, NJ (United States)